Increased expression of plasminogen activator and plasminogen activator inhibitor during liver fibrogenesis of rats: Role of stellate cells

Journal of Hepatology

Volumn 31, Issue 4, 1999, Pages 703-711

  Zhang, Li Ping ^a   Takahara, Terumi ^a,c   Yata, Yutaka ^a   Furui, Kei ^a   Jin, Bo ^a   Kawada, Norifumi ^b   Watanabe, Akiharu ^a  

^a Fac Med   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Second Department of Internal Medicine   (Japan)

Author keywords

Extracellular matrix; Hepatic stellate cell; Liver fibrosis; PAI 1; TGF 1; tPA; uPA; uPAR

Indexed keywords

PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR; TRANSFORMING GROWTH FACTOR BETA1; UROKINASE; UROKINASE RECEPTOR;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; EXTRACELLULAR MATRIX; GENE EXPRESSION; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; KUPFFER CELL; LIVER CELL; LIVER CIRRHOSIS; LIVER FIBROSIS; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; STELLATE CELL;

EID: 0003347632     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(99)80351-1     Document Type: Article

References (59)

1. Friedman SL. The cellular basis of hepatic fibrosis. N Engl J Med. 328:1993;1828-1835.
2. Mayer M. Biomedical and biochemical aspects of the plasminogen activation system. Clin Biochem. 23:1990;197-211.
3. Vassalli JD, Sappino AP, Belin D. The plasminogen activator/plasmin system. J Clin Invest. 88:1991;1067-1072.
4. Andreasen PA, Kjoller L, Christensen L, Duffy MJ. The urokinase-type plasminogen activator system in cancer metastasis: a review. Int J Cancer. 72:1997;1-22.
5. Werb Z, Banda MJ, Jones PA. Degradation of connective tissue matrices by macrophages. I. Proteolysis of elastin, glycoproteins and collagen by proteinases isolated from macrophages. J Exp Med. 152:1980;1340-1357.
6. He C, Wilhelm SM, Pentland AP, Marmer BL, Grant GA, Eisen AZ, et al. Tissue cooperation in a proteolytic cascade activating human interstitial collagenase. Proc Natl Acad Sci USA. 86:1989;2632-2636.
7. Murphy G, Atkinson S, Ward R, Gavrilovic J, Reynolds J. The role of plasminogen activators in the regulation of connective tissue metalloproteinases. Ann N Y Acad Sci. 667:1992;1-12.
8. 1 by plasmin. J Cell Biol. 110:1990;1361-1367.
9. Behrendt N, Ronne E, Dano K. The structure and function of the urokinase receptor, a membrane protein governing plasminogen activation on the cell surface. Biol Chem. 376:1995;269-279.
10. Quax PHA, van den Hoogen CM, Verheijen JH, Padro T, Zeheb R, Gelehrter TD, et al. Endotoxin induction of plasminogen activator and plasminogen activator inhibitor type-1 mRNA in rat tissue in vivo. J Biol Chem. 265:1990;15560-15563.
11. Astrup T. Tissue activators of plasminogen. Fed Proc. 25:1969;42-51.
12. Thornton AJ, Bruzdzinski CJ, Raper SE, Gelehrter TD. Plasminogen activator inhibitor-1 is an immediate early response gene in regenerating rat liver. Cancer Res. 54:1994;1337-1343.
13. Seki T, Imai H, Uno S, Ariga T, Gelehrter TD. Production of tissue-type plasminogen activator(t-PA) and type-1 plasminogen activator inhibitor (PAI-1) in mildly cirrhotic rat liver. Thromb Haemost. 75:1996;801-807.
14. Konkle BA, Schuster SJ, Kelly MD, Harjes K, Hassett DE, Bohrer M, et al. Plasminogen activator inhibitor-1 messenger RNA expression is induced in rat hepatocytes in vivo by dexamethasone. Blood. 79:1992;2636-2647.
15. Seki T, Ariga T, Saito K, Sugawara T, Oshiba S. Hormonal regulation of plasminogen activator production by rat hepatocytes in primary culture. Thromb Res. 58:1990;543-554.
16. Seki T, Watanabe K, Saito K, Ariga T. Purification and characterization of hepatic plasminogen activator (h-PA) in the conditioned medium of rat hepatocytes in primary culture. Biosci Biotech Biochem. 57:1993;1369-1371.
17. Heaton JH, Nebes VL, O'Dell LG, Morris SM, Gelehrter TD. Glucocorticoid and cyclic nucleotide regulation of plasminogen activator and plasminogen activator inhibitor gene expression in primary cultures of rat hepatocytes. Mol Endocrinol. 3:1989;185-192.
18. Kuiper J, Kamps JAAM, Van Berkel TJC. Identification of the inhibitor of the plasminogen activator as the major protein secreted by endothelial rat liver cells. FEBS Lett. 245:1989;229-234.
19. Ramadori G. The stellate cell (Ito-cell, fat-storing cell, lipocyte, perisinusoidal cell) of the liver. Virchows Arch B Cell Pathol. 61:1991;147-158.
20. Iredale JP, Goddard S, Murphy G, Benyon RC, Arthur MJP. Tissue inhibitor of metalloproteinase-1 and interstitial collagenase expression in autoimmune chronic active hepatitis and activated human hepatic lipocytes. Clin Sci. 89:1995;75-81.
21. Arthur MJP, Friedman SL, Roll FL, Bissel DM. Lipocytes from normal rat liver release a neutral metalloproteinase that degrades basement membrane (type IV) collagen. J Clin Invest. 84:1989;1076-1085.
22. Iredale JP, Murphy G, Hembry RM, Friedman SL, Arthur MJP. Human hepatic lipocytes synthesize tissue inhibitor of metalloproteinase-1 (TIMP-1): implications for regulation of matrix degradation in liver. J Clin Invest. 90:1992;282-287.
23. Roeb E, Purucker E, Breuer B, Nguyen H, Heinrich PC, Rose-John S, et al. TIMP expression in toxic and cholestatic liver injury in rat. J Hepatol. 27:1997;535-544.
24. Leyland H, Gentry J, Arthur MJP, Benyon RC. The plasminogen-activating system in hepatic stellate cells. Hepatology. 24:1996;1172-1178.
25. Knittel T, Fellmer P, Ramadori G. Gene expression and regulation of plasminogen activator inhibitor type 1 in hepatic stellate cells of rat liver. Gastroenterology. 111:1996;745-754.
26. Takahara T, Sollberg S, Muona P, Uitto J. Type VI collagen gene expression in experimental liver fibrosis: quantitation and spatial distribution of mRNAs, and immunodetection of the protein. Liver. 15:1995;78-86.
27. Takahara T, Furui K, Funaki J, Nakayama Y, Itoh H, Miyabayashi C, et al. Increased expression of matrix metalloproteinase-II in experimental liver fibrosis in rats. Hepatology. 21:1995;787-795.
28. Kawada N, Seki S, Inoue M, Kuroki T. Effect of antioxidants, resveratrol, quercetin, and N-acetylcysteine, on the functions of cultured rat hepatic stellate cells and Kupffer cells. Hepatology. 27:1998;1265-1274.
29. Braun L, Mead JE, Pamzica M, Mikumo R, Bell GI, Fausto N. Transforming growth factor β mRNA increases during liver regeneration: a possible paracrine mechanism of growth regulation. Proc Natl Acad Sci USA. 85:1988;1539-1543.
30. Ramadori G, Rieder H, Knittel T, Dienes HP, Meyer zum Büschenfelde K-H. Fat storing cells (FSC) of rat liver synthesize and secrete fibronectin: comparison with hepatocytes. J Hepatol. 4:1987;190-197.
31. Tsutsumi M, Takada A, Takase S. Characterization of desminpositive rat liver sinusoidal cells. Hepatology. 7:1987;277-284.
32. Damoiseaux JG, Dopp EA, Calame W, Chao D, MacPherson GG, Dijkstra CD. Rat macrophage lysosomal membrane antigen recognized by monoclonal antibody ED1. Immunology. 83:1994;140-147.
33. Zeheb R, Gelehrter TD. Cloning and sequencing of cDNA for the rat plasminogen activator inhibitor-1. Gene. 73:1988;459-486.
34. Henderson BR, Tansey WP, Phillips SM, Ramshaw IA, Kefford RF. Transcriptional and posttranscriptional activation of urokinase plasminogen activator gene expression in metastatic tumor cells. Cancer Res. 52:1992;2489-2496.
35. Roldan AL, Cubellis MV, Masucci MT, Behrendt N, Lund LR, Danø K, et al. Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis. EMBO J. 9:1990;467-474.
36. Ny T, Leonardsson G, Hsueh AJW. Cloning and characterization of cDNA for rat tissue-type plasminogen activator. DNA. 7:1988;671-677.
37. Derynck R, Jarrett JA, Chen EY, Eaton DH, Bell JR, Assoian RK, et al. Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells. Nature. 316:1985;701-705.
38. Fort P, Marty L, Piechaczyk M, Sabrouty SE, Dani CH, Jeanteur P, et al. Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res. 13:1985;1431-1442.
39. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 18:1979;5294-5299.
40. Takahara T, Furui K, Yata Y, Jin B, Zhang LP, Nambu S, et al. Dual expression of matrix metalloproteinase-2 and membranetype 1-matrix metalloproteinase in fibrotic human livers. Hepatology. 26:1997;1521-1529.
41. Aviv H, Leder P. Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose. Proc Natl Acad Sci USA. 69:1972;1408-1412.
42. Chomczynski P. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue sample. Biotechniques. 15:1993;532-534.
43. Chomczynski P. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue sample. Biotechniques. 15:1993;536-537.
44. Ponte P, Gunning P, Blau H, Kedes L. Human actin genes are single copy for alpha-skeletal and alpha-cardiac actin but multicopy for beta- and gamma-cytoskeletal genes: 3′ untranslated regions are isotype specific but are conserved in evolution. Mol Cell Biol. 3:1983;1783-1791.
45. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
46. Geerts A, Lazou JM, De Bleser P, Wisse E. Tissue distribution, quantitation and proliferation kinetics of fat-storing cells in carbon tetrachloride-injured rat liver. Hepatology. 13:1991;1193-1202.
47. Ellis V, Pyke C, Eriksen J, Solberg H, Dano K. The urokinase receptor: involvement in cell surface proteolysis and cancer invasion. Ann NY Acad Sci. 667:1992;13-31.
48. Friess H, Cantero D, Graber H, Tang WH, Guo XZ, Kashiwagi M, et al. Enhanced urokinase plasminogen activation in chronic pancreatitis suggests a role in its pathogenesis. Gastroenterology. 113:1997;904-913.
49. Shiba M, Shimizu I, Yasuda M, Li K, Ito S. Expression of type I and type III collagens during the course of dimethylnitrosamineinduced hepatic fibrosis in rats. Liver. 18:1998;196-204.
50. Herbst H, Heinrichs O, Schuppan D, Milani S, Stein H. Temporal and spatial patterns of transin/stromelysin RNA expression following toxic injury in rat liver. Virchows Arch B Cell Pathol. 60:1991;295-300.
51. Arthur MJ. Collagenases and liver fibrosis. J Hepatol. 22:1995;43-48.
52. Iredale JP, Benyon RC, Arthur MJ, Ferris WF, Alcolado R, Winwood PJ, et al. Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis. Hepatology. 24:1996;176-184.
53. Eitzman DT, Mccoy RD, Zheng X, Fay WP, Shen T, Ginsburg D, et al. Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene. J Clin Invest. 97:1996;232-237.
54. Oikawa T, Freeman M, Lo W, Vaughan DE, Fogo A. Modulation of plasminogen activator inhibitor-1 in vivo: a new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition. Kidney Int. 51:1997;164-172.
55. Border WA, Noble NA. Transforming growth factor β in tissue fibrosis. N Engl J Med. 331:1994;1286-1292.
56. Yamaguchi Y, Mann DM, Ruoslahti E. Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature. 346:1990;281-284.
57. Busso N, Nicodeme E, Chesne C, Guillouzo A, Belin D, Hyafil F. Urokinase and type I plasminogen activator inhibitor production by normal human hepatocytes: modulation by inflammatory agents. Hepatology. 20:1994;186-190.
58. 1. Hepatology. 18:1993;937-944.
59. Fitch P, Bennett B, Booth NA, Croll A, Ewen SWB. Distribution of plasminogen activator inhibitor in normal liver, cirrhotic liver, and liver with metastases. J Clin Pathol. 47:1994;218-221.